Entry inhibitor

Results: 45



#Item
11F-359-T025  Monoclonal Antibody to CD4 Fluorescein (FITC) conjugated (25 tests) Clone:

1F-359-T025 Monoclonal Antibody to CD4 Fluorescein (FITC) conjugated (25 tests) Clone:

Add to Reading List

Source URL: www.exbio.cz

Language: English
21A-359-T100  Monoclonal Antibody to CD4 Allophycocyanin (APC) conjugated (100 tests) Clone:

1A-359-T100 Monoclonal Antibody to CD4 Allophycocyanin (APC) conjugated (100 tests) Clone:

Add to Reading List

Source URL: www.exbio.cz

Language: English
3PO-359-T100  Monoclonal Antibody to CD4 Pacific Orange™ conjugated (100 tests) Clone:

PO-359-T100 Monoclonal Antibody to CD4 Pacific Orange™ conjugated (100 tests) Clone:

Add to Reading List

Source URL: www.exbio.cz

Language: English
4

PDF Document

Add to Reading List

Source URL: www.exbio.cz

Language: English
5

PDF Document

Add to Reading List

Source URL: www.exbio.cz

Language: English
6Article  Discovery and Characterization of an Endogenous CXCR4 Antagonist Graphical Abstract

Article Discovery and Characterization of an Endogenous CXCR4 Antagonist Graphical Abstract

Add to Reading List

Source URL: www.med.upenn.edu

Language: English - Date: 2015-04-25 16:43:26
7Lara et al. Journal of Nanobiotechnology 2010, 8:1 http://www.jnanobiotechnology.com/contentRESEARCH  Open Access

Lara et al. Journal of Nanobiotechnology 2010, 8:1 http://www.jnanobiotechnology.com/contentRESEARCH Open Access

Add to Reading List

Source URL: www.stdpioneer.org

Language: English - Date: 2011-07-18 21:53:52
8Mutations in the PCNA-binding site of CDKN1C inhibit cell proliferation by impairing the entry into S phase

Mutations in the PCNA-binding site of CDKN1C inhibit cell proliferation by impairing the entry into S phase

Add to Reading List

Source URL: www.celldiv.com

Language: English
9Grants Awarded through the Expression of Interest Process 1 January 2015 to 30 June 2016 Antiviral Targets Professor Paul Gorry. Burnet Institute. Second Generation CCR5 Antagonists as New HIV-1 Entry Inhibitors.

Grants Awarded through the Expression of Interest Process 1 January 2015 to 30 June 2016 Antiviral Targets Professor Paul Gorry. Burnet Institute. Second Generation CCR5 Antagonists as New HIV-1 Entry Inhibitors.

Add to Reading List

Source URL: ach2.publishpath.com

Language: English - Date: 2014-12-17 22:55:09
10Funded Expressions of Interest 1 January 2007 to 30 June 2008 Dr. Mandvi Bharadwaj, The University of Melbourne. ‘Preclinical testing of a recombinant adenovirusbased vaccine to boost Hepatitis C Virus-specific cellula

Funded Expressions of Interest 1 January 2007 to 30 June 2008 Dr. Mandvi Bharadwaj, The University of Melbourne. ‘Preclinical testing of a recombinant adenovirusbased vaccine to boost Hepatitis C Virus-specific cellula

Add to Reading List

Source URL: ach2.publishpath.com

Language: English - Date: 2012-09-03 00:56:52